Overview

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

Status:
Withdrawn
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
A Pilot open labeled study of Tacrolimus in Alzheimer's Disease.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Tacrolimus